Clik here to view.
Bristol-Myers Squibb Announces Cash Tender Offer For Any and All of Certain...
Wednesday, June 14th 2017 at 12:40pm UTC NEW YORK–(BUSINESS WIRE)– Bristol-Myers Squibb Company (NYSE:BMY) announced today that it has commenced a cash tender offer for any and all of its 5.875% Notes...
View ArticleClik here to view.
Pfizer Receives Exclusive Commercialization Rights in Europe for CRESEMBA, a...
Wednesday, June 14th 2017 at 5:20pm UTC Partnership with Basilea Reaffirms Pfizer’s Global Infectious Disease Commitment and Industry Leadership NEW YORK & BASEL, Switzerland–(BUSINESS WIRE)–...
View ArticleClik here to view.
Manhattan Scientifics Schedules Investor Conference Call on Its Affiliate,...
Wednesday, June 14th 2017 at 7:59pm UTC NEW YORK–(BUSINESS WIRE)– Manhattan Scientifics Inc. (OTCQB: MHTX) announced today that it will host a conference call for MHTX investors at 12:00 pm Eastern...
View ArticleClik here to view.
22nd Century Meets with FDA on Modified Risk Tobacco Product Application for...
Friday, June 16th 2017 at 1:25pm UTC CLARENCE, N.Y.–(BUSINESS WIRE)– 22nd Century Group, Inc. (NYSE MKT:XXII), a plant biotechnology company that is a leader in tobacco harm reduction, announced today...
View ArticleClik here to view.
Ipsen annonce que la FDA a approuvé l’autorisation de mise sur le marché du...
Friday, June 16th 2017 at 4:00pm UTC La spasticité peut concerner les adultes souffrant d’un accident vasculaire cérébral, d’un traumatisme crânien, d’une lésion médullaire, d’une sclérose en plaques...
View ArticleClik here to view.
Bristol-Myers Squibb to Sell Manufacturing Facility in Swords, Ireland to SK...
Friday, June 16th 2017 at 8:35am UTC SK Biotek is first Korean company to invest in pharmaceutical manufacturing in Ireland and anticipates further investment by adding R&D, marketing and...
View ArticleClik here to view.
Pfizer Announces Results from XELJANZ® (tofacitinib citrate) ORAL Strategy...
Friday, June 16th 2017 at 8:35am UTC ORAL Strategy is the First Trial to Compare a JAK Inhibitor, XELJANZ, as Monotherapy or in Combination with Methotrexate (MTX) versus Humira® (adalimumab) plus MTX...
View ArticleClik here to view.
Ipsen Announces FDA Approval of Dysport® (Abobotulinumtoxina) for the...
Friday, June 16th 2017 at 4:00pm UTC Spasticity may affect adults who suffer from stroke, traumatic brain injury, spinal cord injury, multiple sclerosis, and cerebral palsy PARIS–(BUSINESS WIRE)–...
View ArticleClik here to view.
Medicrea Highlights UNiD™ ASI Technology at State of Spine Surgery Think Tank...
Wednesday, June 21st 2017 at 10:50pm UTC LYON, France & NEW YORK–(BUSINESS WIRE)– The Medicrea Group (Euronext Growth Paris: FR0004178572 – ALMED), pioneering the convergence of healthcare IT and...
View ArticleClik here to view.
Angion Biomedica Exclusively In-licenses Aldosterone Synthase Inhibitors from...
Thursday, June 22nd 2017 at 11:00am UTC UNIONDALE, N.Y.–(BUSINESS WIRE)– Angion Biomedica Corp. announced today that it has signed an exclusive license with ElexoPharm GmbH of Saarbrücken, Germany,...
View ArticleClik here to view.
Manhattan Scientifics Announces Successful Completion of its Affiliate...
Thursday, June 22nd 2017 at 1:00pm UTC Imagion Biosystems (IBX) to Trade on the Australian (ASX) Stock Exchange NEW YORK–(BUSINESS WIRE)– Manhattan Scientifics Inc. (MHTX), Imagion Biosystems (IBX)...
View ArticleClik here to view.
Kadmon to Present Interim Data on KD025 in Chronic Graft-Versus-Host Disease...
Friday, June 23rd 2017 at 1:00pm UTC — Event on July 11 in New York City with Live Webcast — NEW YORK–(BUSINESS WIRE)– Kadmon Holdings, Inc. (NYSE: KDMN) (“Kadmon” or the “Company”) will present...
View ArticleClik here to view.
Pfizer Declares 32-Cent Third-Quarter 2017 Dividend
Thursday, June 22nd 2017 at 8:05pm UTC NEW YORK–(BUSINESS WIRE)– The board of directors of Pfizer Inc. today declared a 32-cent third-quarter 2017 dividend on the company’s common stock, payable...
View ArticleClik here to view.
Bristol-Myers Squibb Announces the Expiration of its Cash Tender Offer
Wednesday, June 21st 2017 at 10:59am UTC NEW YORK–(BUSINESS WIRE)– Bristol-Myers Squibb Company (NYSE:BMY) announced today the expiration, as of 5:00 p.m., New York City time, on June 20, 2017, of its...
View ArticleClik here to view.
Calyxt Files Registration Statement for Proposed Initial Public Offering
Friday, June 23rd 2017 at 4:45pm UTC ST. PAUL, Minn. & NEW YORK–(BUSINESS WIRE)– class= »bwalignl »> Regulatory News: Cellectis S.A. (Alternext : ALCLS ; Nasdaq : CLLS) and Calyxt, Inc....
View ArticleClik here to view.
Pfizer Begins Phase 1 Clinical Trial to Evaluate Investigational Group B...
Monday, June 19th 2017 at 12:00pm UTC An estimated 10 to 30 percent of pregnant women carry the GBS bacteria;1 the vaccine candidate is being studied to help protect newborns from infection via...
View ArticleClik here to view.
PAREXEL International Enters Definitive Agreement to Be Acquired by Pamplona...
Tuesday, June 20th 2017 at 11:05am UTC BOSTON & NEW YORK–(BUSINESS WIRE)– PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, and Pamplona...
View ArticleClik here to view.
Syntimmune Closes $50 Million Series B Financing Led by Apple Tree Partners
Wednesday, June 21st 2017 at 12:00pm UTC Funds to advance ongoing SYNT001 clinical development, including Phase 1b/2a clinical studies and manufacturing scale-up Syntimmune plans to report SYNT001...
View ArticleClik here to view.
inVentiv Health Selects Medidata Enroll®, Medidata’s eConsent Platform, to...
Monday, June 26th 2017 at 12:30pm UTC inVentiv and Medidata Partner to Expand Use of Patient-Centered Technology to Better Connect Patients, Sites and Biopharmaceutical Clients NEW YORK &...
View ArticleClik here to view.
22nd Century Joins Russell Microcap® Index
Monday, June 26th 2017 at 1:30pm UTC CLARENCE, N.Y.–(BUSINESS WIRE)– 22nd Century Group, Inc. (NYSE MKT:XXII), a plant biotechnology company that is a leader in tobacco harm reduction, announced that,...
View Article